Literature DB >> 6977408

Bone marrow and blood involvement by lymphoma in relationship to the Lukes--Collins classification.

K Foucar, R W McKenna, G Frizzera, R D Brunning.   

Abstract

The incidence, pattern, extent, and morphology of bone marrow involvement in 176 cases of non-Hodgkin's lymphoma (NHL) were studied in relationship to the Lukes--Collins classification. Ninety percent of the cases were B-cell lymphomas; 10% were T-cell lymphomas. In 53% of cases there was bone marrow involvement by lymphoma at diagnosis. Marrow involvement was most frequently found in the small lymphocyte (B), small cleaved follicular center cell (FCC), and convoluted lymphocyte lymphomas. Frequently, the extent of bone marrow biopsy replacement by lymphoma was less than 30%; the pattern of infiltration was predominantly focal (70%). Cytologic agreement between lymph node and bone marrow specimens was always present in small lymphocyte (B), small noncleaved FCC, convoluted lymphocyte, and lymphoepithelioid cell lymphomas. Cytologic diversity between lymph node and marrow was noted in 20% of small cleaved FCC, 40% (2/5) of large cleaved FCC, and 38% (3/8) of large noncleaved FCC lymphomas. In 79% of all involved cases, both bone marrow biopsy sections and aspirate smears were diagnostic of NHL; only biopsy sections were positive in 18%, and only smears were positive in 3%. The Lukes--Collins classification predicts a high incidence of bone marrow involvement for small lymphocyte (B), small cleaved FCC, and convoluted lymphocyte lymphomas.

Entities:  

Mesh:

Year:  1982        PMID: 6977408     DOI: 10.1002/1097-0142(19820301)49:5<888::aid-cncr2820490512>3.0.co;2-k

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  12 in total

1.  Reactive and neoplastic lymphocytes in human bone marrow: morphological, immunohistological, and molecular biological investigations on biopsy specimens.

Authors:  S M Kröber; H P Horny; A Greschniok; E Kaiserling
Journal:  J Clin Pathol       Date:  1999-07       Impact factor: 3.411

2.  Incidence and histological features of bone marrow involvement in malignant lymphomas.

Authors:  G Lambertenghi-Deliliers; C Annaloro; D Soligo; A Oriani; E Pozzoli; N Quirici; R Luksch; E E Polli
Journal:  Ann Hematol       Date:  1992-08       Impact factor: 3.673

3.  Bone involvement in patients with lymphoma: the role of FDG-PET/CT.

Authors:  Niklaus G Schaefer; Klaus Strobel; Christian Taverna; Thomas F Hany
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-09-22       Impact factor: 9.236

4.  Nodular pattern of bone marrow infiltration: frequent finding in immunosuppression-related EBV-associated large B-cell lymphomas.

Authors:  Deborah W Sevilla; Erin M Weeden; Suzy Alexander; Vundavalli V Murty; Bachir Alobeid; Govind Bhagat
Journal:  Virchows Arch       Date:  2009-10-06       Impact factor: 4.064

5.  A Case of Primary Bone Marrow B-Cell Non Hodgkin's Lymphoma with Severe Thrombocytopenia: Case Report and A Review of the Literature.

Authors:  Yuki Kagoya; Naohi Sahara; Takashi Matsunaga; Toshimasa Uekusa; Seiji Irie; Kazuhito Hatanaka
Journal:  Indian J Hematol Blood Transfus       Date:  2010-10-06       Impact factor: 0.900

6.  Bone marrow trephine biopsy in lymphoproliferative disease.

Authors:  P W Bishop
Journal:  J Clin Pathol       Date:  1993-04       Impact factor: 3.411

7.  Lymphoproliferations in the bone marrow: identification and evolution, classification and staging.

Authors:  R Bartl; B Frisch; R Burkhardt; K Jäger; R Pappenberger; G Hoffmann-Fezer
Journal:  J Clin Pathol       Date:  1984-03       Impact factor: 3.411

8.  Focal lymphoid aggregates (nodules) in bone marrow biopsies: differentiation between benign hyperplasia and malignant lymphoma--a practical guideline.

Authors:  J Thiele; T K Zirbes; H M Kvasnicka; R Fischer
Journal:  J Clin Pathol       Date:  1999-04       Impact factor: 3.411

9.  Development of a physiologically based pharmacokinetic model for intravenous lenalidomide in mice.

Authors:  Jim H Hughes; Richard N Upton; Stephanie E Reuter; Darlene M Rozewski; Mitch A Phelps; David J R Foster
Journal:  Cancer Chemother Pharmacol       Date:  2019-09-06       Impact factor: 3.333

10.  Peripheral T cell lymphoma: value of bone marrow trephine immunophenotyping.

Authors:  D M White; A G Smith; J M Whitehouse; J L Smith
Journal:  J Clin Pathol       Date:  1989-04       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.